Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON OTCMKTS:STDAF NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$0.97-0.3%$1.02$0.84▼$2.38$436.71M0.795.00 million shs1.08 million shsCRONCronos Group$2.75-1.1%$2.73$1.92▼$3.43$1.04B0.89880,072 shs374,093 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$4.42+0.7%$5.06$4.20▼$23.20$511.65M1.893.32 million shs3.13 million shsUSNAUSANA Health Sciences$22.07+0.2%$19.34$16.60▼$38.32$406.74M0.73108,501 shs69,850 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-0.28%-2.88%-3.84%-7.50%-22.92%CRONCronos Group-1.08%-3.85%+0.36%+6.59%+32.21%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+0.68%-4.33%-11.95%-32.72%-34.53%USNAUSANA Health Sciences+0.10%+2.67%+14.86%+21.30%-32.63%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$0.97-0.3%$1.02$0.84▼$2.38$436.71M0.795.00 million shs1.08 million shsCRONCronos Group$2.75-1.1%$2.73$1.92▼$3.43$1.04B0.89880,072 shs374,093 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$4.42+0.7%$5.06$4.20▼$23.20$511.65M1.893.32 million shs3.13 million shsUSNAUSANA Health Sciences$22.07+0.2%$19.34$16.60▼$38.32$406.74M0.73108,501 shs69,850 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-0.28%-2.88%-3.84%-7.50%-22.92%CRONCronos Group-1.08%-3.85%+0.36%+6.59%+32.21%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+0.68%-4.33%-11.95%-32.72%-34.53%USNAUSANA Health Sciences+0.10%+2.67%+14.86%+21.30%-32.63%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 2.17HoldN/AN/ACRONCronos Group 2.20Hold$2.30-16.36% DownsideSTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ATLRYTilray Brands 2.25Hold$11.50160.18% UpsideUSNAUSANA Health Sciences 1.50ReduceN/AN/ACurrent Analyst Ratings BreakdownLatest CGC, TLRY, STDAF, CRON, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/29/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/24/2026USNAUSANA Health Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)6/15/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/1/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/18/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/13/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/29/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/22/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 7/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$251.01M1.74N/AN/A$1.13 per share0.86CRONCronos Group$146.59M7.00$0.01 per share221.74$3.00 per share0.92STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78TLRYTilray Brands$821.31M0.63$1.45 per share3.04$14.04 per share0.31USNAUSANA Health Sciences$925.26M0.44$4.14 per share5.33$29.16 per share0.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$190.29M-$0.59N/AN/AN/A-75.27%-26.95%-17.20%8/7/2026 (Estimated)CRONCronos Group-$9.45M$0.01275.28N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$13.65N/AN/AN/A-156.51%-3.31%-2.42%7/27/2026 (Estimated)USNAUSANA Health Sciences$10.76M$0.4746.957.970.870.96%6.21%4.50%7/28/2026 (Estimated)Latest CGC, TLRY, STDAF, CRON, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2026Q1 2027CGCCanopy Growth-$0.04N/AN/AN/A$58.21 millionN/A8/6/2026Q2 2026CRONCronos Group$0.01N/AN/AN/A$44.20 millionN/A7/28/2026Q2 2026USNAUSANA Health Sciences$0.43N/AN/AN/A$235.00 millionN/A7/27/2026Q4 2026TLRYTilray Brands-$0.01N/AN/AN/A$251.23 millionN/A6/15/2026Q4 2026CGCCanopy Growth-$0.06-$0.17-$0.11-$0.05$53.43 million$51.22 million5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$45.21 million5/5/2026Q1 2026USNAUSANA Health Sciences$0.44$0.61+$0.17$0.41$240.99 million$250.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.313.342.64CRONCronos GroupN/A21.8720.73STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99TLRYTilray Brands0.192.791.66USNAUSANA Health SciencesN/A2.511.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth0.16%CRONCronos Group7.80%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands0.84%USNAUSANA Health Sciences0.82%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth1,128448.42 million447.70 millionOptionableCRONCronos Group450373.03 million343.94 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableTLRYTilray Brands2,842116.55 million115.57 millionOptionableUSNAUSANA Health Sciences1,57018.46 million18.31 millionOptionableCGC, TLRY, STDAF, CRON, and USNA HeadlinesRecent News About These CompaniesKevin Guest: World Cup Determination Shows the Power of Grit, Preparation, PersistenceJuly 1, 2026 | prnewswire.com5 Low P/B Stocks That Investors Can Add to Their Portfolio in JulyJune 30, 2026 | zacks.comUSANA Health Sciences (NYSE:USNA) Shares Cross Above 200 Day Moving Average - Here's What HappenedJune 30, 2026 | americanbankingnews.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?June 26, 2026 | zacks.com4 Value Stocks to Buy as Lower Energy Costs Strengthen Market OutlookJune 25, 2026 | zacks.comBrent Neidig Sells 5,002 Shares of USANA Health Sciences (NYSE:USNA) StockJune 19, 2026 | insidertrades.comUSANA Health Sciences: How The Restructuring Plan Makes It A Strong BuyJune 18, 2026 | seekingalpha.comUSANA Celebrates 10 Years of Making the World a Better Place During World Service WeekJune 16, 2026 | prnewswire.com5 Low Price-to-Book Stocks That Are Worth Buying in JuneJune 12, 2026 | zacks.comThese 4 Low Price-to-Cash Flow Stocks Have Winning PotentialJune 11, 2026 | zacks.comAre Investors Undervaluing USANA Health Sciences (USNA) Right Now?June 10, 2026 | zacks.comUSANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare ProductsJune 8, 2026 | finance.yahoo.comUSANA Earns Dual Best of State Honors for Product Innovation and DevelopmentJune 4, 2026 | prnewswire.comUSANA Health Sciences (NYSE:USNA) Director Sells $43,928.50 in StockJune 2, 2026 | insidertrades.com1 stock under $50 with promising prospects and 2 we brush offJune 1, 2026 | msn.comKevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness MonthJune 1, 2026 | prnewswire.comUSANA Health Sciences (NYSE:USNA) CFO Sells $100,500.00 in StockMay 29, 2026 | insidertrades.comUSANA Health Sciences (NYSE:USNA) Director Gilbert Fuller Sells 1,057 SharesMay 27, 2026 | insidertrades.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?May 25, 2026 | zacks.com4 Top Value Stocks to Buy Now as Wall Street Takes Fresh NoticeMay 22, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMicron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026Apple Just Handed These 4 Memory Stocks Their Best News of the YearBy Bridget Bennett | June 28, 2026SK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026Micron’s HBM Surge Could Redefine the AI Growth StoryBy Thomas Hughes | June 25, 2026Is the Memory Rally Still Alive After the Semiconductor Sell-Off?By Jessica Mitacek | July 2, 2026CGC, TLRY, STDAF, CRON, and USNA Company DescriptionsCanopy Growth NASDAQ:CGC$0.97 0.00 (-0.28%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.98 +0.00 (+0.39%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.75 -0.03 (-1.08%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$2.78 +0.03 (+1.20%) As of 07/10/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Tilray Brands NASDAQ:TLRY$4.42 +0.03 (+0.68%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$4.42 0.00 (-0.11%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$22.06 +0.04 (+0.16%) Closing price 07/10/2026 03:59 PM EasternExtended Trading$22.04 -0.02 (-0.09%) As of 07/10/2026 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab’s Stock Drop Comes With a Bullish Twist Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth PepsiCo’s Dividend Could Turn Patience Into Real Profit Lockheed Martin Secures the Ultimate Defense Moat Why Levi's Digital Strategy Is Paying Off in a Big Way Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
